PATTON, LAURA
PATTON, LAURA
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
2007 Pasquali R.; Patton L.; Pocognoli P.; Cognigni G.E.; Gambineri A.
Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome
2021 Pandurevic, Srdan; Bergamaschi, Luca; Pizzi, Carmine; Patton, Laura; Rucci, Paola; Corzani, Francesca; Cecchetti, Carolina; Pelusi, Carla; Altieri, Paola; Vicennati, Valentina; Di Dalmazi, Guido; Fanelli, Flaminia; Macut, Djuro; Pagotto, Uberto; Gambineri, Alessandra
High serum concentration of total inhibin in polycystic ovary syndrome
2008 Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F.
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
2007 Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R.
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.
2012 Gambineri A;Patton L;Altieri P;Pagotto U;Pizzi C;Manzoli L;Pasquali R
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men.
2005 Gambineri A.; Pagotto U.; De Lasio R.; Meriggiola M.C.; Costantino A.; Patton L.; Pelusi C.; Pelusi G.; Pasquali R.
Sindrome dell'ovaio policistico e diabete di tipo 2
2004 Patton L.; Gambineri A.; Vaccina A.; Pasquali R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. | Pasquali R.; Patton L.; Pocognoli P.; Cognigni G.E.; Gambineri A. | 2007-01-01 | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - | 1.01 Articolo in rivista | - |
| Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome | Pandurevic, Srdan; Bergamaschi, Luca; Pizzi, Carmine; Patton, Laura; Rucci, Paola; Corzani, Franc...esca; Cecchetti, Carolina; Pelusi, Carla; Altieri, Paola; Vicennati, Valentina; Di Dalmazi, Guido; Fanelli, Flaminia; Macut, Djuro; Pagotto, Uberto; Gambineri, Alessandra | 2021-01-01 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | - | 1.01 Articolo in rivista | Pandurevic.pdf |
| High serum concentration of total inhibin in polycystic ovary syndrome | Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F. | 2008-01-01 | FERTILITY AND STERILITY | - | 1.01 Articolo in rivista | - |
| Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. | Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R. | 2007-01-01 | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - | 1.01 Articolo in rivista | - |
| Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. | Gambineri A;Patton L;Altieri P;Pagotto U;Pizzi C;Manzoli L;Pasquali R | 2012-01-01 | DIABETES | - | 1.01 Articolo in rivista | - |
| Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. | Gambineri A.; Pagotto U.; De Lasio R.; Meriggiola M.C.; Costantino A.; Patton L.; Pelusi C.; Pelu...si G.; Pasquali R. | 2005-01-01 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| Sindrome dell'ovaio policistico e diabete di tipo 2 | Patton L.; Gambineri A.; Vaccina A.; Pasquali R. | 2004-01-01 | BULLETTINO DELLE SCIENZE MEDICHE | - | 1.01 Articolo in rivista | - |